Table 3 Nuclear expression of β-catenin and non-phospho β-catenin. Relationship with clinical outcome of COX-2 inhibitor therapy
Favorable group (n = 20) | Unfavorable group (n = 20) | p value | |
|---|---|---|---|
β-catenina | 0.16 | ||
weak | 2 | 4 | |
moderate | 14 | 8 | |
strong | 4 | 8 | |
non-phospho β-catenin | 0.11 | ||
negative | 3 | 1 | |
weak | 13 | 8 | |
moderate | 4 | 9 | |
strong | 0 | 2 |